Elotuzumab 68225-0245
Product NDC
68225-0245- Manufacturer
- Patheon Italia S.p.a.
- Dosage Form
- Injection, Powder, Lyophilized, For Solution
- Product Type
- Drug For Further Processing
- Marketing Start
- March 8, 2024
- Listing Expires
- December 31, 2026
Active Ingredients
| Ingredient | Strength |
|---|---|
| Elotuzumab | 300 mg/1 |
Packaging Options(1)
144 VIAL in 1 BOX (68225-245-00) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL